Lipoprotein lipase and hepatic lipase: Their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II)

Journal of Lipid Research

Volumn 44, Issue 8, 2003, Pages 1552-1558

  Cheung, Marian C ^a   Sibley, Shalamar D ^a,c   Palmer, Jerry P ^a,b   Oram, John F ^a   Brunzell, John D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Veterans Administration   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

High density lipoprotein size profile; Phospholipid transfer protein; Type 1 diabetes

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID COMPOSITION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; CARRIER PROTEINS; FEMALE; HEPARIN; HUMANS; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOLIPID TRANSFER PROTEINS; SEX CHARACTERISTICS;

EID: 0142010584     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300091-JLR200     Document Type: Article

References (60)

1. Johansson, J., L. A. Carlson, C. Landou, and A. Hamsten. 1991. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler. Thromb. 11: 174-182.
2. Cheung, M. C., B. G. Brown, A. C. Wolf, and J. J. Albers. 1991. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J. Lipid Res. 32: 383-394.
3. Cheung, M. C., and J. J. Albers. 1984. Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 258: 12201-12209.
4. James, R. W., A. Proudfoot, and D. Pometta. 1989. Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. Biochim. Biophys. Acta. 1002: 292-301.
5. Cheung, M. C., J. P. Segrest, J. J. Albers, J. T. Cone, C. G. Brouillette, B. H. Chung, M. Kashyap, M. A. Glasscock, and G. M. Anantharamaiah. 1987. Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. J. Lipid Res. 28: 913-929.
6. Rader, D.J., G. Castro, L. A. Zech, J. C. Fruchart, and H. B. Brewer. 1991. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. J. Lipid Res. 32: 1849-1859.
7. Tilly-Kiesi, M., A. Lichtenstein, J. Joven, E. Vilella, M. C. Cheung, W. V. Carrasco, J. M. Ordovas, G. Dolinikowski, and E. J. Schaefer. 1997. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects. Arterioscler. Thromb. Vasc. Biol. 17: 3513-3518.
8. Atmah, R. F., J. Shepherd, and C.J. Packard. 1983. Subpopulations of apolipoprotein A-I in human high density lipoproteins. Their metabolic properties and response to drug therapy. Biochim. Biophys. Acta. 751: 175-188.
9. Cheung, M. C., X. Q. Zhao, J. W. Davis, J. J. Albers, A. Chait, and B. G. Brown. 2001. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler. Thromb. 21: 1320-1326.
10. Delplanque, B., J. L. Richard, and B. Jacotot. 1991. Influence of diet on the plasma levels and distribution of apoA-I-containing lipoprotein particles. Prog. Lipid Res. 30: 159-170.
11. Cheung, M. C.,A. H. Lichtenstein, and E.J. Schaefer. 1994. Effects of a diet restricted in saturated fatty acids and cholesterol on the composition of apolipoprotein A-I-containing lipoprotein particles in the fasting and fed states. Am. J. Clin. Nutr. 60: 911-918.
12. Cheung, M. C., C. E. Walden, and R. H. Knopp. 1999. Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles. Metabolism. 48: 658-664.
13. Brinton, E. A. 1996. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler. Thromb. Vasc. Biol. 16: 431-440.
14. Puchois, P., A. Kandoussi, P. Fievet, J. L. Fourier, M. Bertrand, E. Koren, and J. C. Fruchart. 1987. Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis. 68: 35-40.
15. Decossin, C., G. Castro, B. Derudas, M. Bertrand,J-C. Fruchart, and C. Fievet. 1997. Subclasses of LpA-I in coronary artery disease: distribution and cholesterol efflux ability. Eur. J. Clin. Invest. 27: 299-307.
16. Mowri, H-O., W. Patsch, L. C. Smith, A. M. Gotto, and J. R. Patsch. 1992. Different reactivities of high density lipoprotein 2 subfractions with hepatic lipase. J. Lipid Res. 23: 1269-1279.
17. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
18. Huuskonen, J., V. M. Olkkonen, M. Jauhiainen, and C. Ehnholm. 2001. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis. 155: 269-281.
19. Kuusi, T., C. Ehnholm, J. Viikari, R. Harkonen, E. Vartiainen, P. Puska, and M-R. Taskinen. 1989. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J. Lipid Res. 30: 1117-1126.
20. Nevin, D. N., A. Zambon, C. E. Furlong, R.J. Richter, R. Humbert, J. E. Hokanson, and J. D. Brunzell. 1996. Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler. Thromb. Vasc. Biol. 16: 1243-1249.
21. Murdoch, S. J., M. C. Carr, J. E. Hokanson, J. D. Brunzell, and J. J. Albers. 2000. PLTP activity in premenopausal women, Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J. Lipid Res. 41: 237-244.
22. Kahri, J., G. Per-Henrik, G. Viberti, T. Elliott, and M-R. Taskinen. 1993. Regulation of apolipoprotein A-I-containing lipoproteins in IDDM. Diabetes. 42: 1281-1288.
23. Frenais, R., H. Nazih, K. Ouguerram, C. Maugeais, Y. Zair, J. M. Bard, B. Charbonnel, T. Magot, and M. Krempf. 2001. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein Al metabolism: a kinetic study in control subjects and patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 86: 1962-1967.
24. De Oliveira e Silva, E., M. Kong, Z. Han, C. Starr, E. M. Kass, S. H. Juo, D. Foster, H. M. Dansky, M. Merkel, K. Cundey, E. A. Brinton, J. L. Breslow, and J. D. Smith. 1999. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J. Lipid Res. 40: 1211-1221.
25. Albers, J. J., G. W. Wolfbauer, M. C. Cheung, J. R. Day, A. F. T. Ching, S. Lok, and A-Y. Tu. 1995. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim. Biophys. Acta. 1258: 27-34.
26. The Diabetes Control and Complications Group. 1986. The Diabetes Control and Complications Trial: design and methodologic considerations for the feasibility phase. Diabetes. 35: 530-545.
27. United States Department of Health and Human Services. 1980. Department of Health and Human Services: The Prevalence Study. U.S. Government Printing Office, Washington, D.C.
28. Metropolitan Life Insurance Company. 1983. Metropolitan height and weight tables. Stat. Bull. Metrop. Life Found. 64: 3-9.
29. Cheung, M. C., and A. C. Wolf. 1989. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins. J. Lipid Res. 30: 499-509.
30. Cheung, M. C., A. C. Wolf, and J. D. Brunzell. 1990. Metabolic pathways of HDL subpopulations physiological implications of in vitro observations. In Disorders of HDL. L. A. Carlson, editor. Smith-Gordon and Co. Ltd., London. 89-97.
31. Iverius, P. H., and J. D. Brunzell. 1985. Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. Am. J. Physiol. 249: E107-E114.
32. Cheung, M. C., G. Wolfbauer, and J. J. Albers. 1996. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim. Biophys. Acta. 1303: 103-110.
33. Warnick, G. R. 1986. Enzymatic methods for the quantification of lipoprotein lipids. In. Methods in Enzymology. J. J. Albers and. J. P. Segrest, editors. Academic Press, New York. 129: 101-123.
34. Warnick, G. R., J. Benderson, and J. J. Albers. 1982. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
35. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin. Chem. 18: 449-502.
36. Cheung, M. C., R. H. Knopp, B. Retzlaff, H. Kennedy, G. Wolfbauer, and J. J. Albers. 2002. Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity. Biochim. Biophys. Acta. 1587: 53-59.
37. Brunzell, J. D., and S. S. Deeb. 2001. Familial lipoprotein lipase deficiency, apo CII deficiency and hepatic lipase deficiency. In The Metabolic and Molecular Basis of Inherited Disease, 8th edition. R. S. Scriver, A. L. Beaudet, E. S. Sly, D. Vale, editors. McGraw-Hill Book Co., New York. 2789-2816.
38. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707.
39. Taskinen, M-R., and T. Kuusi. 1987. Enzymes involved in triglyceride hydrolysis. Baillieres Clin. Metab. 1: 639-666.
40. 2, cholesterol. Arterioscler. Thromb. Vasc. Biol. 18: 1723-1729.
41. Hime, N. J., P. J. Barter, and K-A. Rye. 1998. The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol. J. Biol. Chem. 273: 27191-27198.
42. Kahri, J., G. Per-Henrik, T. Elliott, G. C. Viberti, and M-R. Taskinen. 1994. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy. Diabetes Care. 17: 412-419.
43. Collet, X., A. R. Tall, H. Serajuddin, K. Guendouzi, L. Royer, H. Oliveira, R. Barbaras, X-C. Jiang, and O. L. Francone. 1999. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-1. J. Lipid Res. 40: 1185-1193.
44. Tall, A. R., S. Krumholz, and T. Olivercrona. 1985. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J. Lipid Res. 26: 842-851.
45. Tollefson, J. H., S. Ravnik, and J. J. Albers. 1988. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J. Lipid Res. 29: 1593-1602.
46. Murdoch, S. J., and W. C. Breckenridge. 1996. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL. Biochim. Biophys. Acta. 1303: 222-232.
47. Jiang, X. C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduced high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
48. Tu, A. Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
49. Von Eckardstein, A., M. Jauhianinen, Y. Huang, J. Metso, C. Langer, P. Pusinen, S. Wu, C. Ehnholm, and G. Assmann. 1996. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre-β1-HDL. Biochim. Biophys. Acta. 1301: 255-262.
50. Dullaart, R. P., W. J. Sluiter, L. D. Dikkeschei, K. Hoogenberg, and A. Van Tol. 1994. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur. J. Clin. Invest. 24: 188-194.
51. Cheung, M. C., G. Wolfbauer, B. G. Brown, and J. J. Albers. 1999. Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease. Atherosclerosis. 142: 201-205.
52. Jiang, X. C., S. Qin, C. Qiao, K. Kawano, M. Lin, A. Skold, X. Xiao, and A. R. Tall. 2001. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat. Med. 7: 847-852.
53. Colvin, P. L., E. Moriguchi, H. Barrett, J. Parks, and L. Rudel. 1998. Production rate determines plasma concentration of large high density lipoprotein in non-human primates. J. Lipid Res. 39: 1076-2085.
54. Colvin, P. L., E. Moriguchi, P. H. R. Barrett, J. S. Parks, and L. L. Rudel. 1999. Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates. J. Lipid Res. 40: 1782-1792.
55. Cheung, M. C., A. C. Wolf, R. H. Knopp, and D. M. Foster. 1992. Protein transfer between A-I-containing lipoprotein subpopulations: evidence of non-transferable A-I in particles with A-II. Biochim. Biophys. Acta. 1165: 68-77.
56. Rinninger, K., M. Brundert, I. Brosch, N. Donarski, R. M. Budzinski, and H. Greten. 2001. Lipoprotein lipase mediates an increase in selective uptake of HDL-associated cholesteryl esters by cells in culture independent of scavenger receptor B1. J. Lipid Res. 42: 1740-1751.
57. Medh, J. D., G. L. Fry, S. L. Bowen, S. Ruben, H. Wong, and D. A. Chappell. 2000. Lipoprotein lipase and hepatic lipase promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism. J. Lipid Res. 41: 1858-1871.
58. Lambert, G., M. B. Chase, K. Dugi, A. Bensadoun, H. B. Brewer, Jr. and S. Santamarina-Fojo. 1999. Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J. Lipid Res. 40: 1294-1303.
59. Wolfbauer, G., J. J. Albers, and J. F. Oram. 1999. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim. Biophys. Acta. 1439: 65-76.
60. Clay, M. A., D. Pyle, K-A. Rye, and P. J. Barter. 2000. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase. J. Biol. Chem. 275: 9019-9025.